Header cover image

Hong Kong (HSI) Biotech Industry Analysis

UpdatedJan 19, 2022
DataAggregated Company Financials
  • 7D-0.8%
  • 3M-24.0%
  • 1Y-39.2%
  • YTD-3.5%

Over the last 7 days, the Biotech industry has remained flat, although notably Shanghai Junshi Biosciences gained 25%. As for the longer term, the industry has declined 39% in the last year.

Industry Valuation and Performance

Has the Hong Kong Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Thu, 20 Jan 2022HK$381.4bHK$31.1b-HK$31,891,209,285.0013.2x
Sat, 18 Dec 2021HK$431.5bHK$31.1b-HK$31,849,546,921.0013.5x
Mon, 15 Nov 2021HK$489.1bHK$31.0b-HK$31,744,501,684.0014.4x
Wed, 13 Oct 2021HK$493.9bHK$30.5b-HK$31,492,826,100.0014.6x
Fri, 10 Sep 2021HK$528.3bHK$30.4b-HK$31,412,511,864.3917.6x
Sun, 08 Aug 2021HK$541.3bHK$30.2b-HK$32,058,827,347.3513.6x
Sat, 01 May 2021HK$572.9bHK$27.8b-HK$26,637,487,691.0916.9x
Tue, 02 Feb 2021HK$532.5bHK$24.0b-HK$26,645,675,939.7566.8x
Fri, 06 Nov 2020HK$321.9bHK$20.1b-HK$11,752,667,554.4042.7x
Mon, 10 Aug 2020HK$372.4bHK$17.2b-HK$11,180,934,453.5956.1x
Sun, 03 May 2020HK$234.2bHK$16.9b-HK$10,102,316,008.1529.1x
Wed, 05 Feb 2020HK$176.6bHK$17.1b-HK$7,752,252,997.1840.7x
Sat, 09 Nov 2019HK$164.7bHK$16.0b-HK$8,602,972,653.4121.7x
Fri, 02 Aug 2019HK$126.2bHK$15.5b-HK$8,892,457,780.7216.8x
Mon, 06 May 2019HK$130.4bHK$14.9b-HK$8,334,412,400.4518.3x
Thu, 07 Feb 2019HK$94.6bHK$14.1b-HK$6,309,891,852.0714.2x
PE Ratio


Total Market Cap: HK$94.6bTotal Earnings: -HK$6,309,891,852.07Total Revenue: HK$14.1b0%0%0%3 Year10 Year

Current Industry PE: Investors are more pessimistic on the industry, considering it's trading at a PE ratio of 13.2x which is lower than its 3-year average PE of 28.8x. It appears they believe that earnings will not grow as fast as they have historically.

Past Earnings Growth: The earnings for companies in the Biotechs industry have deteriorated over the last three years, while revenues for these companies have grown 30% per year. This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Hong Kong Biotech industry?


Industry PE: Investors are most optimistic about the Biotech industry even though it's trading below its 3-year average PE ratio of 28.8x. However analysts expect its future annual earnings growth (48%) to be largely in line with prior year's earnings growth, so the market might believe analysts are underestimating its future growth since investors are willing to pay a bigger premium today.

Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 48% over the next 5 years. This is roughly in line with its past earnings growth rate.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1877 Shanghai Junshi BiosciencesHK$57.6024.5%
1672 Ascletis PharmaHK$6.8269.2%
9966 Alphamab OncologyHK$13.243.4%
2616 CStone PharmaceuticalsHK$7.804.7%
1167 Jacobio Pharmaceuticals GroupHK$12.523.3%
Simply Wall Stâ„¢
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News